Stockscreener 앱 받기
10.11
5.13%
0.46
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Chief Financial Officer Moran Sean F. was granted 27,500 shares, increasing direct ownership by 57% to 76,105 units (SEC Form 4) - Quantisnow
CRBP stock touches 52-week low at $9.26 amid market challenges - MSN
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Stock Position Lifted by JPMorgan Chase & Co. - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Sees Significant Decline in Short Interest - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
(CRBP) Proactive Strategies - Stock Traders Daily
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference - GlobeNewswire
Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Exclusive: Corbus Pharmaceuticals Reveals Strategic Vision at Elite Biotech Conference - StockTitan
CRBP stock touches 52-week low at $10.43 amid market fluctuations - Investing.com Australia
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 9.1% in December - MarketBeat
Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Decreases By 9.1% - Defense World
Brokerages Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Target Price at $62.00 - Defense World
Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded to Sell at StockNews.com - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $62.00 Average Price Target from Brokerages - MarketBeat
Dermatomyositis Market to Show Remarkable Growth Trends from - openPR
Corbus Pharmaceuticals Holdings, Inc. Announces Clinical Data for CRB-701 from Western Dose Escalation Study to Be Presented at ASCO GU 2025 - Marketscreener.com
Corbus Pharmaceuticals Announces that Clinical Data for - GlobeNewswire
Corbus Pharmaceuticals to Present CRB-701 Cancer Drug Trial Data at ASCO GU 2025 Symposium - StockTitan
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025 - The Manila Times
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Geode Capital Management LLC - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Sees Large Growth in Short Interest - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Update - MarketBeat
How to Take Advantage of moves in (CRBP) - Stock Traders Daily
State Street Corp Buys 153,243 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by State Street Corp - MarketBeat
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Stock Holdings Boosted by Fmr LLC - Defense World
Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Target Price at $62.00 - Defense World
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $62.00 - MarketBeat
(CRBP) Investment Report - Stock Traders Daily
Mizuho remains bullish on Corbus stock, sees encouraging outlook for Nectin-4 ADC - Investing.com Canada
Charles Schwab Investment Management Inc. Buys 64,800 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
0.43%
3.18%
자본화:
|
볼륨(24시간):